Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement in hematological neoplasias.

F J Batlle Fonrodona, M F López Fernández, V Vicente García

    Allergologia Et Immunopathologia
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery.

    Haemophilia : the official journal of the World Federation of Hemophilia·2015
    Same author

    Haemovigilance for the optimal use of blood products in the hospital.

    Vox sanguinis·2010
    Same author

    [Deep venous thrombosis: therapeutic considerations].

    Revista clinica espanola·2005
    Same author

    [Clinical assessment of the preventive use of antiplatelet drugs].

    Revista clinica espanola·2004
    Same author

    [Correction].

    Sangre·1999
    Same journal

    Peach sublingual immunotherapy for lipid transfer protein syndrome.

    Allergologia et immunopathologia·2026
    Same journal

    Gastrointestinal stenosis: an underrecognized complication of CARMIL2 deficiency.

    Allergologia et immunopathologia·2026
    Same journal

    Peach sublingual immunotherapy for lipid transfer protein syndrome.

    Allergologia et immunopathologia·2026
    Same journal

    Vitamin B12 allergy and desensitization.

    Allergologia et immunopathologia·2026
    Same journal

    Chronic HBV infection, stemness pathways, and compromised immune surveillance in HCC development.

    Allergologia et immunopathologia·2026
    Same journal

    Application of FeNO in the diagnostic and therapeutic algorithm of pediatric asthma: From chronic cough and wheeze to personalized management.

    Allergologia et immunopathologia·2026
    See all related articles

    Complement levels (CH50) were elevated in most hematological neoplasias, particularly Hodgkin's disease and acute leukemia, suggesting a role for complement in these cancers.

    Area of Science:

    • Immunology
    • Hematology
    • Oncology

    Background:

    • The complement system is crucial in immune responses.
    • Alterations in complement may be linked to neoplastic diseases.

    Purpose of the Study:

    • To investigate complement system component levels in various hematological malignancies.
    • To explore potential correlations between complement activation and cancer progression.

    Main Methods:

    • Quantification of total hemolytic complement (CH50) using a modified Kabat and Mayer method.
    • Measurement of eight complement antigenic fractions (C1q, C1s, C3, C4, C5, INHC1, C3A, properdin) via Manani and Laurell's techniques.
    • Analysis of complement levels in 30 patients across non-Hodgkin's lymphomas, chronic lymphocytic leukemia, Hodgkin's disease, acute leukemia, chronic myeloid leukemia, and multiple myeloma.

    Related Experiment Videos

    Main Results:

    • Significant increases in CH50 were observed in Hodgkin's disease, acute leukemia, and chronic myeloid leukemia.
    • Elevated levels of C1s, C3, C4, C5, C9, and C3A were noted in specific hematological neoplasia groups.
    • No significant variations in C1s, INHC1, and properdin were found across the studied groups.
    • No correlation was established between the clinical course of the disease and complement levels.

    Conclusions:

    • The complement system shows significant activation in various hematological malignancies.
    • Specific complement components may serve as potential biomarkers for certain cancers.
    • Further research is warranted to elucidate the precise role of complement in neoplastic disease pathogenesis.